HomeNDC LookupDrug shortages › Hydrocortisone Acetate Suppository

Hydrocortisone Acetate Suppository shortage

Hydrocortisone Acetate Suppository is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 21, 2026.

To Be Discontinued ⚠ Supply risk: High Analgesia/Addiction, Other 2 products 60 days First posted Jul 23, 2026 Updated Jul 23, 2026
Here’s the bottom line

Padagis is permanently stopping production of hydrocortisone acetate suppositories. Other makers — including the brand Anucort-HC — still list both the 25 mg and 30 mg strengths as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
2
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/2
Affected strengths supplied
60
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 21, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Hydrocortisone Acetate Suppository. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
2 NDCs
To be discontinued 2
Affected strengths still supplied
Among manufacturers reporting this shortage
0/2 strengths
No supply 2
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Hydrocortisone Acetate Suppository from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Cosette Pharmaceuticals, Inc. Major Pharmaceuticals Marlex Pharmaceuticals, Inc. Laser Pharmaceuticals, LLC Rising Pharma Holdings, Inc. APNAR PHARMA LP Patrin Pharma Inc. A-S Medication Solutions
Plus 12 alternative dosage forms of Hydrocortisone Acetate.
See all other options & details →
Shortage timeline
  1. Jul 23, 2026
    Currently in shortage
    2 of 2 products affected.
  2. Jul 23, 2026
    First reported to the FDA
    2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Padagis US LLC 📞 (800) 775-2054 2 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) NDC 00574-7090-12 Discontinuation of the manufacture of the drug
To Be Discontinued Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) NDC 00574-7093-12 Discontinuation of the manufacture of the drug

These rows are manufacturer reports to the FDA for Hydrocortisone Acetate Suppository — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Hydrocortisone Acetate Suppository? options further down this page.

Why is Hydrocortisone Acetate Suppository in shortage?

Padagis US LLC has reported to the FDA that they are permanently stopping production of their hydrocortisone acetate suppositories — specifically the 25 mg and 30 mg strengths, both in 12-count packages. This isn't a temporary supply hiccup or a factory delay; the company has made a decision to stop manufacturing these two products altogether.

It's worth knowing that this report only reflects what Padagis has shared with the FDA. No specific reason was given for why they made this business decision — just that the discontinuation is permanent. Other manufacturers of hydrocortisone acetate suppositories may not be affected by this same decision, as this report covers only Padagis and their specific products.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Hydrocortisone Acetate Suppository, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Hydrocortisone Acetate Suppository?

Hydrocortisone acetate suppositories are currently listed on the FDA shortage report. This record covers one manufacturer, Padagis US LLC, and both of its strengths — the 25 mg and the 30 mg — are affected. Neither strength has an available source from this maker right now.

The reason listed for both strengths is that the manufacturer is discontinuing production. This means the supply problem from Padagis may be permanent rather than temporary. That said, this report reflects only one company, and the same medicine is made by several other manufacturers, so it may still be available from a different source through your pharmacy.

Here is how I would approach it:

  • Please do not stop or change how you use your suppositories on your own.
  • Ask your pharmacy to check whether the same medicine (hydrocortisone acetate suppository, in your 25 mg or 30 mg strength) is available from another maker. Companies such as Cosette, Major, Marlex, Laser, Rising, APNAR, Patrin, and others make the same product, though it may not be in local stock.
  • Since Padagis is discontinuing this item, talk with your prescriber or pharmacist about your options if a replacement cannot be found.

Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls.

This is general national information and may not match your local pharmacy's actual stock.

See “Where else can I get Hydrocortisone Acetate Suppository?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Hydrocortisone guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Hydrocortisone guide →

Where else can I get Hydrocortisone Acetate Suppository?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Hydrocortisone Acetate Suppository is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Hydrocortisone Acetate HYDROCORTISONE ACETATE 30 mg/1 Suppository · Rectal Cosette Pharmaceuticals, Inc. 00713-0493-12
Anucort-Hc HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Cosette Pharmaceuticals, Inc. 00713-0503-01
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Major Pharmaceuticals 00904-7340-12
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Marlex Pharmaceuticals, Inc. 10135-0751-12
Hemmorex-Hc HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Laser Pharmaceuticals, LLC 16477-0201-12
Hemmorex-Hc HYDROCORTISONE ACETATE 30 mg/1 Suppository · Rectal Laser Pharmaceuticals, LLC 16477-0202-12
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Rising Pharma Holdings, Inc. 16571-0676-21
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal APNAR PHARMA LP 24689-0102-01
Hydrocortisone Acetate HYDROCORTISONE ACETATE 30 mg/1 Suppository · Rectal APNAR PHARMA LP 24689-0103-01
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal Patrin Pharma Inc. 39328-0029-12
Hydrocortisone Acetate HYDROCORTISONE ACETATE 30 mg/1 Suppository · Rectal Patrin Pharma Inc. 39328-0129-12
Hydrocortisone Acetate HYDROCORTISONE ACETATE 25 mg/1 Suppository · Rectal A-S Medication Solutions 50090-6331-00

Alternative dosage forms of Hydrocortisone Acetate

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Hydrocortisone Acetate 25 mgNDC 24689-0102-01 APNAR 12 suppositories $1.101 FDA listed
Hydrocortisone Acetate 25 mgNDC 00574-7090-12 Padagis 12 suppositories FDA listed
Anucort-Hc 25 mgNDC 00713-0503-01 Cosette 100 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 00904-7340-12 Major 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 10135-0751-12 Marlex 12 suppositories FDA listed
Hemmorex-HC 25 mgNDC 16477-0201-12 Laser 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 16571-0676-21 Rising 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 39328-0029-12 Patrin 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 50090-6331-00 A-S 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 50268-0411-01 AvPAK 100 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 51407-0665-12 Golden 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 63629-2530-01 Bryant 12 suppositories FDA listed
Anusol HC 25 mgNDC 65649-0411-12 Salix 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 68071-2259-02 NuCare 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 69367-0243-12 Westminster 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 70752-0169-02 QUAGEN 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 71205-0976-12 Proficient 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 75834-0147-12 Nivagen 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 82568-0150-01 AARNA 12 suppositories FDA listed
Hydrocortisone Acetate 25 mgNDC 68788-4190-01 Preferred 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 00574-7093-12 Padagis 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 00713-0493-12 Cosette 12 suppositories FDA listed
Hemmorex-HC 30 mgNDC 16477-0202-12 Laser 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 16571-0164-21 Rising 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 24689-0103-01 APNAR 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 39328-0129-12 Patrin 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 63629-2531-01 Bryant 12 suppositories FDA listed
Proctocort 30 mgNDC 65649-0511-12 Salix 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 69367-0260-12 Westminster 12 suppositories FDA listed
Hydrocortisone Acetate 30 mgNDC 82568-0160-01 AARNA 12 suppositories FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Identity & classification

GCN Seq No 006858
GCN 27941
HICL code 002863
Ingredient (HICL) Hydrocortisone Acetate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3A
Therapeutic class — specific (HIC3) Rectal Preparations
AHFS code 84:06.08.00
AHFS class Corticosteroids (Skin, Mucous Membrane)
FDB label name HYDROCORTISONE AC 25 MG SUPP
FDB brand name Hydrocortisone Acetate
Legend status F — Federal legend — prescription drug or device
GPI-1489100010105230
GPI classHydrocortisone Acetate
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Hydrocortisone Acetate Suppository shortage FAQs

Is Hydrocortisone Acetate Suppository in shortage?
Yes — the FDA currently lists Hydrocortisone Acetate Suppository in shortage (status: “To Be Discontinued”, first reported Jul 23, 2026). 2 of 2 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) (NDC 00574-7090-12); Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) (NDC 00574-7093-12). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Hydrocortisone Acetate Suppository be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Hydrocortisone Acetate somewhere?
Other manufacturers (Cosette Pharmaceuticals, Inc., Major Pharmaceuticals, Marlex Pharmaceuticals, Inc. and others) still market it and have not reported a shortage. 12 alternative dosage forms of Hydrocortisone Acetate are also listed. See “Where else can I get Hydrocortisone Acetate Suppository?” above — stock still varies by pharmacy.
What should I do if I take Hydrocortisone Acetate Suppository?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Hydrocortisone Acetate Suppository shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages